Additionally, the stability of RanGAP1 mRNA was found to be reduced following METTL3 knockdown, as demonstrated by treating CRC cells with a transcription inhibitor (actinomycin D) for a specified period (Fig. 4G, Fig. S3L). The gene discussed is METTL3; the disease is colorectal carcinoma.